FR3024237B1 - Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose - Google Patents
Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thromboseInfo
- Publication number
- FR3024237B1 FR3024237B1 FR1457219A FR1457219A FR3024237B1 FR 3024237 B1 FR3024237 B1 FR 3024237B1 FR 1457219 A FR1457219 A FR 1457219A FR 1457219 A FR1457219 A FR 1457219A FR 3024237 B1 FR3024237 B1 FR 3024237B1
- Authority
- FR
- France
- Prior art keywords
- thrombosis
- football
- fibrin
- bleeding
- predict
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Ecology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1457219A FR3024237B1 (fr) | 2014-07-25 | 2014-07-25 | Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose |
US15/326,120 US20170234853A1 (en) | 2014-07-25 | 2015-07-24 | Method for determining the structural profile of a fibrin clot reflecting the stability thereof, in order to predict the risk of bleeding, thrombosis or rethrombosis |
BR112017001492A BR112017001492A2 (pt) | 2014-07-25 | 2015-07-24 | método para determinar o perfil estrutural de um coágulo de fibrina refletindo a sua estabilidade para previnir o risco de hemorragia, trombose ou retrombose |
JP2017503954A JP2017523413A (ja) | 2014-07-25 | 2015-07-24 | 出血(bleeding)、血栓症または再血栓症のリスクの予測を目的とした、フィブリンクロットの、その安定性を反映する構造プロファイルを決定するための方法 |
PCT/FR2015/052050 WO2016012729A1 (fr) | 2014-07-25 | 2015-07-24 | Methode de determination du profil de structure d'un caillot de fibrine refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose |
EP15754272.1A EP3177921A1 (fr) | 2014-07-25 | 2015-07-24 | Methode de determination du profil de structure d'un caillot de fibrine refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1457219A FR3024237B1 (fr) | 2014-07-25 | 2014-07-25 | Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3024237A1 FR3024237A1 (fr) | 2016-01-29 |
FR3024237B1 true FR3024237B1 (fr) | 2016-08-05 |
Family
ID=51932386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1457219A Expired - Fee Related FR3024237B1 (fr) | 2014-07-25 | 2014-07-25 | Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose |
Country Status (6)
Country | Link |
---|---|
US (1) | US20170234853A1 (fr) |
EP (1) | EP3177921A1 (fr) |
JP (1) | JP2017523413A (fr) |
BR (1) | BR112017001492A2 (fr) |
FR (1) | FR3024237B1 (fr) |
WO (1) | WO2016012729A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
FR3048001B1 (fr) * | 2016-02-18 | 2018-02-09 | Diagnostica Stago | Methode de dosage des d-dimeres specifiques de la maladie thromboembolique veineuse |
JP7101351B2 (ja) | 2016-04-28 | 2022-07-15 | シスメックス株式会社 | 血液検体の分析方法、血液検体分析用試薬及び試薬キット、並びに血液検体分析装置 |
FR3127043A1 (fr) * | 2021-09-14 | 2023-03-17 | Diagnostica Stago | Mesure in vitro de la lyse d’un caillot de fibrine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2623142C (fr) * | 2004-09-22 | 2016-01-19 | The Regents Of The University Of Colorado, A Body Corporate | Methodes de test global de la coagulation et de la fibrinolyse |
US20130065260A1 (en) | 2009-11-06 | 2013-03-14 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, Methods and Uses for Simultaneous Assay of Thrombin and Plasmin Generation |
EP2677037B1 (fr) * | 2012-06-21 | 2016-04-13 | Synapse B.V. | Mesure simultanée de la génération de thrombine et résistance des caillots dans du plasma et du sang entier |
US9500639B2 (en) * | 2012-07-18 | 2016-11-22 | Theranos, Inc. | Low-volume coagulation assay |
-
2014
- 2014-07-25 FR FR1457219A patent/FR3024237B1/fr not_active Expired - Fee Related
-
2015
- 2015-07-24 WO PCT/FR2015/052050 patent/WO2016012729A1/fr active Application Filing
- 2015-07-24 JP JP2017503954A patent/JP2017523413A/ja active Pending
- 2015-07-24 BR BR112017001492A patent/BR112017001492A2/pt not_active IP Right Cessation
- 2015-07-24 EP EP15754272.1A patent/EP3177921A1/fr not_active Withdrawn
- 2015-07-24 US US15/326,120 patent/US20170234853A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR3024237A1 (fr) | 2016-01-29 |
US20170234853A1 (en) | 2017-08-17 |
EP3177921A1 (fr) | 2017-06-14 |
JP2017523413A (ja) | 2017-08-17 |
BR112017001492A2 (pt) | 2017-12-05 |
WO2016012729A1 (fr) | 2016-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3292116T3 (da) | 3-aryl-4-amido-bicykliske [4,5,0]hydroxamsyrer som hdac-inhibitorer | |
DK3283511T3 (da) | Modified collagen, methods of manufacture thereof | |
MA43761A (fr) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj | |
BR112015024856A2 (pt) | métodos de determinação ou de monitoramento | |
DK3410970T3 (da) | Forankringsskrue med kondenseringsattributter | |
DK3283535T3 (da) | Polymerer omfattende imidazoliumkationer med eksceptionel alkalisk stabilitet | |
DK3297485T3 (da) | Løbesko med snøring | |
DK3619363T3 (da) | Profil | |
FR3024237B1 (fr) | Methode de determination du profil de structure d'un caillot de fibrine, refletant sa stabilite, pour predire le risque de saignement, de thrombose ou de re-thrombose | |
FR3017625B1 (fr) | Methode predictive pour determiner la radiosensibilite tissulaire | |
EP3298161A4 (fr) | Procédés, systèmes et compositions de détermination de formation de caillot de sang, et utilisations associées | |
BR112017026552A2 (pt) | gel de bimatoprosta oftálmico administrável sob forma de gota. | |
FR3037983B1 (fr) | Huisserie neuve ou de renovation | |
FR3029418B1 (fr) | Composition destinee a ralentir les signes du vieillissement pathologique ou physiologique. | |
FR3015039B1 (fr) | Procede de determination de la position d'au moins un pion de cartographie | |
FR3021843B1 (fr) | Methode et composition pour ameliorer la productivite de plantes non legumineuses | |
FR3048859B1 (fr) | Vitrage isolant, notamment pour meuble climatique | |
IL251605A0 (en) | Use of protein in predicting intracorporeal phenomena | |
WO2016100549A3 (fr) | Céramides à utiliser pour évaluer un risque de maladie cardiovasculaire | |
FI20155841A (fi) | Arviointijärjestelmä ja -menetelmä ainakin yhden topologioista makrotopologia, millitopologia, mikrotopologia ja nanotopologia määrittämiseksi | |
FR3017713B1 (fr) | Procede et kit pour determiner la probabilite pour un patient d'evoluer vers une dengue severe | |
FR3034522B1 (fr) | Procede de determination de la duree de vie des porteurs | |
FR3031820B1 (fr) | Procede de determination de la validite d'un modele | |
FR3027492B1 (fr) | Egrappoir separateur-trieur de la vendange | |
IT201600102071A1 (it) | Forma per calzature e procedimento per la sua realizzazione. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
EXTE | Extension to a french territory |
Extension state: PF |
|
PLSC | Publication of the preliminary search report |
Effective date: 20160129 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
ST | Notification of lapse |
Effective date: 20200306 |